Work

O-009 Prognostic value of BRAFV600E and KRAS exon 2 mutations in microsatellite stable stage III colon cancers from patients treated with FOLFOX + /- cetuximab: A pooled analysis from PETACC8 and N0147 trials

Year: 2015

Type: conference-abstract

Source: Annals of Oncology

DOI: 10.1093/annonc/mdv235.08

Authors: J. Taieb, K. Le Malicot, F. Penault-Llorca, O. Bouche, Q. Shi, S. Thibodeau, J. Tabernero, E. Mini, Z. Zaanan, R. Goldberg, G. Folprecht, J.L. Van Laethem, D. Sargent, S. Alberts, P. Laurent Puig, F. Sinicrope

Institutions: Hôpital Européen Georges-Pompidou, Fédération Francophone de Cancérologie Digestive, Centre Jean Perrin, Centre Hospitalier Universitaire de Reims, Mayo Clinic, Vall d'Hebron Hospital Universitari, Vall d'Hebron Institute of Oncology, University of Florence, The Ohio State University, University Hospital Carl Gustav Carus, Erasmus Hospital, Mayo Clinic Comprehensive Cancer Center (Minnesota), Inserm, Université Paris Descartes

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2285816487

Cites:

Cited by:

Related to: 10